157 related articles for article (PubMed ID: 7520015)
1. Desmin and neural marker expression in mesothelial cells and mesotheliomas.
Hurlimann J
Hum Pathol; 1994 Aug; 25(8):753-7. PubMed ID: 7520015
[TBL] [Abstract][Full Text] [Related]
2. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells.
Davidson B; Nielsen S; Christensen J; Asschenfeldt P; Berner A; Risberg B; Johansen P
Am J Surg Pathol; 2001 Nov; 25(11):1405-12. PubMed ID: 11684957
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Popper H; Wirnsberger G; Hoefler H; Denk H
Cancer Detect Prev; 1987; 10(3-4):167-74. PubMed ID: 2436780
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
Cagle PT; Truong LD; Roggli VL; Greenberg SD
Am J Clin Pathol; 1989 Nov; 92(5):566-71. PubMed ID: 2479255
[TBL] [Abstract][Full Text] [Related]
5. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.
Churg A
Am J Surg Pathol; 1985 May; 9(5):360-5. PubMed ID: 2418692
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours.
Garcia-Prats MD; Ballestin C; Sotelo T; Lopez-Encuentra A; Mayordomo JI
Histopathology; 1998 May; 32(5):462-72. PubMed ID: 9639123
[TBL] [Abstract][Full Text] [Related]
8. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.
Attanoos RL; Griffin A; Gibbs AR
Histopathology; 2003 Sep; 43(3):231-8. PubMed ID: 12940775
[TBL] [Abstract][Full Text] [Related]
9. Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon.
Mayall FG; Goddard H; Gibbs AR
Histopathology; 1992 Nov; 21(5):453-7. PubMed ID: 1280615
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models.
Ferrandez-Izquierdo A; Navarro-Fos S; Gonzalez-Devesa M; Gil-Benso R; Llombart-Bosch A
Diagn Cytopathol; 1994; 10(3):256-62. PubMed ID: 7519540
[TBL] [Abstract][Full Text] [Related]
11. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma.
Flint A; Weiss SW
Hum Pathol; 1995 Apr; 26(4):428-31. PubMed ID: 7535740
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
Hyun TS; Barnes M; Tabatabai ZL
Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evidence of the mesothelial histogenesis of a uterine adenomatoid tumor.
Satoh Y; Hiraguchi M; Matuura T; Takasu K
J Obstet Gynaecol Res; 1998 Apr; 24(2):91-101. PubMed ID: 9631596
[TBL] [Abstract][Full Text] [Related]
14. Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma.
Epstein JI; Budin RE
Hum Pathol; 1986 May; 17(5):514-9. PubMed ID: 2422109
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.
Zeng L; Fleury-Feith J; Monnet I; Boutin C; Bignon J; Jaurand MC
Hum Pathol; 1994 Mar; 25(3):227-34. PubMed ID: 7512071
[TBL] [Abstract][Full Text] [Related]
17. Desmin expression in reactive mesothelium: a potential aid in evaluation of gynecologic specimens.
Kupryjańczyk J; Karpińska G
Int J Gynecol Pathol; 1998 Apr; 17(2):123-8. PubMed ID: 9553808
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.
Kortsik CS; Werner P; Freudenberg N; Virchow JC; Kroegel C; Pott M; Matthys H
Lung; 1995; 173(2):79-87. PubMed ID: 7536281
[TBL] [Abstract][Full Text] [Related]
19. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture.
LaRocca PJ; Rheinwald JG
Cancer Res; 1984 Jul; 44(7):2991-9. PubMed ID: 6202404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
